CS

Chaitali Sarkar

Director Director DIN 08259312
DIN 08259312 First appointment Oct 2018 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Oct 2018
Shareholding value Locked Premium profile

About Chaitali Sarkar

Chaitali Sarkar has 7 years in corporate governance. Formerly with 1 company, such as Boneym Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 08259312
Primary Designation Director
First Appointment 17 Oct 2018
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

Company Designation Appointment Founded Status
Director 17 Oct 2018 2018 Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Boneym Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Chaitali Sarkar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Chaitali Sarkar

Chaitali Sarkar has 7 years in corporate governance. Formerly with 1 company, such as Boneym Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

Chaitali Sarkar is associated with 0 companies as a director.

Chaitali Sarkar has expertise in General Business.

Chaitali Sarkar has 7 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available